On this week’s episode, we delve into a subject that afflicts millions of people around the world: chronic obstructive pulmonary disease, or COPD.
With inhaler prices soaring, patients find themselves grappling with a heartbreaking choice: compromised respiratory health or financial strain. This dilemma raises profound questions about the accessibility and affordability of life-saving treatments.
Today we explore the intertwined narratives of climate change, high drug costs and the far-reaching consequences for respiratory health.
Our guests were:
- Dr. Sebastian Fernandez-Bussy, director of interventional pulmonology at Mayo Clinic in Jacksonville. He specializes in minimally invasive diagnostic and therapeutic thoracic procedures.
- Britney Hazelett, interventional pulmonology nurse lead and assistant professor of nursing, also at Mayo Clinic.
- Lisa Kosak, a COPD patient.
